The standard version of IrriSept is packaged and intended for use in any
non-sterile environment.
As the only FDA-Cleared Cleansing and Debridement system with CHG, IrriSept offers an alternative to traditional saline irrigation.
System Contents:
IrriSept
(1) Each 450 mL bottle contains 0.05% Chlorhexidine Gluconate (CHG) in water for irrigation, USP (99.95%). Sterile, Non-Pyrogenic (fluid only).
IrriRinse
(1) Each 450 mL bottle contains 0.9% Sodium Chloride Irrigation USP. No antimicrobial agent has been added. ph 5.5. (4.5 to 7.0). Osmolarity 308 mOsmo/L (calc.). Sterile, Non-Pyrogenic (fluid only). Isotonic solution for Irrigation only.
Features
- Average time to discharge bottle < 30 seconds per bottle
- Self-contained, portable
- Single use, disposable
- Generates variable pressures with manual compression
- Patented SplatterGuard and LT SplatterGuard applicators included (please see the Applicators page for details and usage)
Why it's better:
The IrriSept delivery method and SplatterGuard reduce biohazard contamination that can contribute to Hospital-Acquired Infections (HAI's), including potential exposure to Staph, MRSA, HIV, VRE and Hepatitis. The patented SplatterGuard, placed over the wound, reduces splatter during the irrigation procedure, helping protect healthcare professionals and reducing aerosolized contamination.
The unique delivery system of IrriSept with Chlorhexidine Gluconate (CHG), is engineered to optimize cleansing and debridement and meets the American College of Emergency Physicians (ACEP) guidelines for volume and pressure.1
IrriSept passed the FDA required tests for cytotoxicity, skin irritation and immune (allergic) response.1
Examples of IrriSept® use include:
- Skin & Soft Tissue Infections (SSTIs)
- Abscesses
- Delayed closures
- "Road Rash" abrasions
- Lacerations
- Deep traumatic wounds
- Dehiscence
- Puncture wounds
- Burns
- Pilonidal Cysts
IrriSept is indicated for use on wounds. Contraindicated for patients with CHG allergy. Keep away from eyes and ear canals; if there is contact with these areas, rinse out promptly and thoroughly with water or normal saline.
1. Biocompatibility compliance tests completed per FDA's Blue Book Memorandum G95-1 and ISO 10993-1, Biological Evaluation of Medical Devices, on file at IRRIMAX Corporation
